Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 5 | 2025 | 324 | 2.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2024 | 327 | 2.060 |
Why?
|
| Phosphate-Binding Proteins | 3 | 2024 | 18 | 1.800 |
Why?
|
| Interferon Type I | 2 | 2023 | 169 | 1.380 |
Why?
|
| Nucleotidyltransferases | 4 | 2025 | 58 | 1.350 |
Why?
|
| Pyroptosis | 4 | 2024 | 31 | 1.280 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2025 | 8 | 0.980 |
Why?
|
| Lipoylation | 1 | 2024 | 4 | 0.910 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 258 | 0.810 |
Why?
|
| Dimethyl Fumarate | 1 | 2020 | 8 | 0.700 |
Why?
|
| Familial Mediterranean Fever | 1 | 2020 | 9 | 0.700 |
Why?
|
| Membrane Proteins | 2 | 2023 | 850 | 0.690 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 57 | 0.680 |
Why?
|
| Cysteine | 1 | 2020 | 107 | 0.670 |
Why?
|
| Inflammation | 3 | 2025 | 1099 | 0.660 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2019 | 10 | 0.660 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 220 | 0.650 |
Why?
|
| Neutrophils | 1 | 2021 | 365 | 0.610 |
Why?
|
| Signal Transduction | 2 | 2025 | 2900 | 0.580 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 207 | 0.570 |
Why?
|
| Histones | 1 | 2020 | 457 | 0.560 |
Why?
|
| Animals | 13 | 2025 | 19650 | 0.470 |
Why?
|
| Immunity, Innate | 3 | 2024 | 774 | 0.380 |
Why?
|
| Colitis | 2 | 2023 | 74 | 0.370 |
Why?
|
| Mice | 9 | 2025 | 10291 | 0.360 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2021 | 250 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 3231 | 0.280 |
Why?
|
| Cell Nucleus | 2 | 2020 | 608 | 0.260 |
Why?
|
| Macrophages | 2 | 2023 | 1015 | 0.250 |
Why?
|
| Nucleotides, Cyclic | 1 | 2025 | 16 | 0.240 |
Why?
|
| Mutation | 2 | 2025 | 2456 | 0.240 |
Why?
|
| Herpesvirus 1, Human | 1 | 2025 | 78 | 0.230 |
Why?
|
| Humans | 10 | 2025 | 59389 | 0.220 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2024 | 100 | 0.220 |
Why?
|
| Lysosomes | 1 | 2024 | 160 | 0.220 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2023 | 10 | 0.210 |
Why?
|
| Interferons | 1 | 2023 | 61 | 0.210 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 16 | 0.200 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 94 | 0.190 |
Why?
|
| Interleukin-18 | 1 | 2021 | 71 | 0.180 |
Why?
|
| NF-kappa B | 1 | 2023 | 460 | 0.180 |
Why?
|
| RNA, Long Noncoding | 1 | 2023 | 152 | 0.180 |
Why?
|
| Thrombosis | 1 | 2023 | 182 | 0.180 |
Why?
|
| Ubiquitination | 1 | 2021 | 106 | 0.180 |
Why?
|
| Myeloid Cells | 1 | 2021 | 89 | 0.180 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 26 | 0.170 |
Why?
|
| Dysbiosis | 1 | 2021 | 56 | 0.170 |
Why?
|
| RNA Precursors | 1 | 2020 | 74 | 0.170 |
Why?
|
| Macrophage Activation | 1 | 2020 | 118 | 0.170 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 297 | 0.170 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2024 | 397 | 0.170 |
Why?
|
| Apoptosis | 1 | 2025 | 1033 | 0.170 |
Why?
|
| NLR Proteins | 1 | 2019 | 11 | 0.160 |
Why?
|
| DNA Viruses | 1 | 2019 | 14 | 0.160 |
Why?
|
| Caspases | 1 | 2020 | 166 | 0.160 |
Why?
|
| Caspase 1 | 1 | 2019 | 107 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 146 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 258 | 0.150 |
Why?
|
| DNA | 1 | 2023 | 805 | 0.150 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 480 | 0.150 |
Why?
|
| HEK293 Cells | 1 | 2020 | 587 | 0.150 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 623 | 0.150 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 627 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 411 | 0.130 |
Why?
|
| Intestinal Mucosa | 2 | 2024 | 225 | 0.100 |
Why?
|
| Intestines | 2 | 2024 | 158 | 0.100 |
Why?
|
| Pseudomonas Infections | 1 | 2024 | 51 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 127 | 0.060 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 35 | 0.050 |
Why?
|
| Cyclic GMP | 1 | 2023 | 28 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 124 | 0.050 |
Why?
|
| Male | 2 | 2021 | 27749 | 0.050 |
Why?
|
| Platelet Activation | 1 | 2023 | 26 | 0.050 |
Why?
|
| Proteome | 1 | 2023 | 141 | 0.050 |
Why?
|
| Female | 2 | 2021 | 30726 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2023 | 92 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2023 | 259 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2024 | 240 | 0.050 |
Why?
|
| Virus Replication | 1 | 2023 | 305 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 95 | 0.050 |
Why?
|
| Epitopes | 1 | 2022 | 286 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2023 | 215 | 0.050 |
Why?
|
| Homeostasis | 1 | 2023 | 346 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 446 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 292 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 313 | 0.040 |
Why?
|
| Mitochondria | 1 | 2023 | 343 | 0.040 |
Why?
|
| Monocytes | 1 | 2021 | 345 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1051 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 920 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 858 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 1471 | 0.030 |
Why?
|